Dexbrompheniramine
 | |
| Clinical data | |
|---|---|
| Trade names | Drixoril, Conex, Dixaphedrine |
| AHFS/Drugs.com | Multum Consumer Information |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Elimination half-life | 25 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.004.595 |
| Chemical and physical data | |
| Formula | C16H19BrN2 |
| Molar mass | 319.246 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Dexbrompheniramine is an antihistamine with anticholinergic properties[1] used to treat allergic conditions such as hay fever or urticaria. It is the pharmacologically active dextrorotatory isomer of brompheniramine. It was formerly marketed in combination with pseudoephedrine under the name Drixoral in the US and Canada. It is an alkylamine antihistamine.
Dexbrompheniramine is a first generation antihistamine that reduces the effects of the neurotransmitter histamine in the body: sneezing, itching, watery eyes, and runny nose.
Interactions
[edit]MAO inhibitors within 14 days. MAO inhibitors include isocarboxazid, linezolid, phenelzine, rasagiline, selegiline, and tranylcypromine.
Drinking alcohol can increase side effects of dexbrompheniramine.
References
[edit]External links
[edit]
Media related to Dexbrompheniramine at Wikimedia Commons
 | This drug article relating to the respiratory system is a stub. You can help Wikipedia by adding missing information. |
 | This stereochemistry article is a stub. You can help Wikipedia by adding missing information. |
 | This article about an amine is a stub. You can help Wikipedia by adding missing information. |
